Novel motif:50: Difference between revisions
From FANTOM5_SSTAR
(Created page with "{{Novel_motif
|name=motif50_GTCCNA
|novel_motifs_human_sample_pval=11376-118A8_11051;0.646562,11327-117E4_11969;0.65588,11473-119C6_11054;0.69553,11474-119C7_12067;0.667514,...") |
No edit summary |
||
(3 intermediate revisions by the same user not shown) | |||
Line 1: | Line 1: | ||
{ | |||
Latest revision as of 14:46, 9 September 2013
name: | motif50_GTCCNA |
---|
Association to promoter expression in human samples<b>Summary:</b>Significance of the correlation with CAGE expression, human <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
Association to promoter expression in mouse samples
<b>Summary:</b>Significance of the correlation with CAGE expression, mouse <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
GREAT analysis results for human
<b>Summary:</b>Genomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon<br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0051001 | negative regulation of nitric-oxide synthase activity | 1.543495e-9 |
GO:0035269 | protein O-linked mannosylation | 3.681316e-9 |
GO:0015742 | alpha-ketoglutarate transport | 3.011886e-8 |
GO:0046655 | folic acid metabolic process | 8.358726e-8 |
GO:0072109 | glomerular mesangium development | 1.419236e-7 |
GO:0006457 | protein folding | 1.606816e-7 |
GO:2000249 | regulation of actin cytoskeleton reorganization | 1.881829e-7 |
GO:0045947 | negative regulation of translational initiation | 4.938949e-7 |
GO:0050909 | sensory perception of taste | 5.306801e-7 |
GO:0043249 | erythrocyte maturation | 5.575751e-7 |
GO:0030853 | negative regulation of granulocyte differentiation | 7.023668e-7 |
GO:0000956 | nuclear-transcribed mRNA catabolic process | 1.219870e-6 |
GO:0000288 | nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay | 1.486196e-6 |
GO:0072301 | regulation of metanephric glomerular mesangial cell proliferation | 1.865095e-6 |
GO:0006415 | translational termination | 1.925446e-6 |
GO:0043241 | protein complex disassembly | 2.683473e-6 |
GO:0072110 | glomerular mesangial cell proliferation | 3.335516e-6 |
GO:0007274 | neuromuscular synaptic transmission | 4.167013e-6 |
GO:0006414 | translational elongation | 5.092434e-6 |
GO:0019058 | viral infectious cycle | 5.569305e-6 |
GO:0042254 | ribosome biogenesis | 6.427232e-6 |
GO:0031365 | N-terminal protein amino acid modification | 6.807930e-6 |
GO:0032754 | positive regulation of interleukin-5 production | 7.444741e-6 |
GO:0019083 | viral transcription | 8.119354e-6 |
GO:0060712 | spongiotrophoblast layer development | 8.137884e-6 |
GO:0006402 | mRNA catabolic process | 8.752253e-6 |
GO:0006401 | RNA catabolic process | 9.142603e-6 |
GO:0043624 | cellular protein complex disassembly | 9.277312e-6 |
GO:0060457 | negative regulation of digestive system process | 1.059976e-5 |
GO:0071816 | tail-anchored membrane protein insertion into ER membrane | 1.129760e-5 |
GO:0016072 | rRNA metabolic process | 1.150181e-5 |
GO:0060713 | labyrinthine layer morphogenesis | 1.274240e-5 |
GO:0010424 | DNA methylation on cytosine within a CG sequence | 1.405561e-5 |
GO:0060711 | labyrinthine layer development | 1.510089e-5 |
GO:0006760 | folic acid-containing compound metabolic process | 1.804256e-5 |
GO:0002502 | peptide antigen assembly with MHC class I protein complex | 1.861318e-5 |
GO:0006304 | DNA modification | 2.750508e-5 |
GO:0006364 | rRNA processing | 2.794465e-5 |
GO:0071504 | cellular response to heparin | 2.797466e-5 |
GO:0046618 | drug export | 2.804246e-5 |
GO:0017148 | negative regulation of translation | 2.894724e-5 |
GO:0043045 | DNA methylation involved in embryo development | 3.039460e-5 |
GO:0051973 | positive regulation of telomerase activity | 3.091292e-5 |
GO:0030719 | P granule organization | 3.192900e-5 |
GO:0071593 | lymphocyte aggregation | 3.392742e-5 |
GO:0031848 | protection from non-homologous end joining at telomere | 3.528790e-5 |
GO:0040030 | regulation of molecular function, epigenetic | 3.932592e-5 |
GO:2000251 | positive regulation of actin cytoskeleton reorganization | 3.932592e-5 |
GO:0070489 | T cell aggregation | 3.972720e-5 |
GO:0030421 | defecation | 3.972720e-5 |
GO:0032202 | telomere assembly | 4.090073e-5 |
GO:0060708 | spongiotrophoblast differentiation | 4.116830e-5 |
GO:0002268 | follicular dendritic cell differentiation | 4.614832e-5 |
GO:0009142 | nucleoside triphosphate biosynthetic process | 4.696145e-5 |
GO:0033233 | regulation of protein sumoylation | 4.963080e-5 |
GO:0010897 | negative regulation of triglyceride catabolic process | 5.048116e-5 |
GO:0010987 | negative regulation of high-density lipoprotein particle clearance | 5.048116e-5 |
GO:0007199 | G-protein signaling, coupled to cGMP nucleotide second messenger | 5.358055e-5 |
GO:0001977 | renal system process involved in regulation of blood volume | 5.497784e-5 |
GO:0032984 | macromolecular complex disassembly | 5.583916e-5 |
GO:0031619 | homologous chromosome orientation involved in meiotic metaphase I plate congression | 5.850360e-5 |
GO:0009258 | 10-formyltetrahydrofolate catabolic process | 6.049519e-5 |
GO:0003105 | negative regulation of glomerular filtration | 6.330099e-5 |
GO:0051668 | localization within membrane | 6.712614e-5 |
GO:0050779 | RNA destabilization | 6.729343e-5 |
GO:0060669 | embryonic placenta morphogenesis | 7.096145e-5 |
GO:0051205 | protein insertion into membrane | 7.298885e-5 |
GO:0070172 | positive regulation of tooth mineralization | 7.307570e-5 |
GO:0046499 | S-adenosylmethioninamine metabolic process | 7.598915e-5 |
GO:0006505 | GPI anchor metabolic process | 7.653605e-5 |
GO:0009145 | purine nucleoside triphosphate biosynthetic process | 8.010997e-5 |
GO:0060306 | regulation of membrane repolarization | 8.053327e-5 |
GO:0042558 | pteridine-containing compound metabolic process | 8.348579e-5 |
GO:0090196 | regulation of chemokine secretion | 9.210421e-5 |
GO:0071503 | response to heparin | 9.210421e-5 |
GO:0009206 | purine ribonucleoside triphosphate biosynthetic process | 9.492237e-5 |
GO:0018023 | peptidyl-lysine trimethylation | 9.828032e-5 |
GO:0061101 | neuroendocrine cell differentiation | 9.877936e-5 |
GO:0006506 | GPI anchor biosynthetic process | 1.005504e-4 |
GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening | 1.078533e-4 |
GO:0006700 | C21-steroid hormone biosynthetic process | 1.140907e-4 |
GO:0009201 | ribonucleoside triphosphate biosynthetic process | 1.145702e-4 |
GO:0030968 | endoplasmic reticulum unfolded protein response | 1.153262e-4 |
GO:0006400 | tRNA modification | 1.209326e-4 |
GO:0006695 | cholesterol biosynthetic process | 1.277871e-4 |
GO:0045842 | positive regulation of mitotic metaphase/anaphase transition | 1.402428e-4 |
GO:0016126 | sterol biosynthetic process | 1.432967e-4 |
GO:0060591 | chondroblast differentiation | 1.444704e-4 |
GO:0034445 | negative regulation of plasma lipoprotein particle oxidation | 1.473462e-4 |
GO:0002478 | antigen processing and presentation of exogenous peptide antigen | 1.508793e-4 |
GO:0034623 | cellular macromolecular complex disassembly | 1.548722e-4 |
GO:0043089 | positive regulation of Cdc42 GTPase activity | 1.603513e-4 |
GO:0060621 | negative regulation of cholesterol import | 1.653234e-4 |
GO:0032864 | activation of Cdc42 GTPase activity | 1.653234e-4 |
GO:0046939 | nucleotide phosphorylation | 1.673942e-4 |
GO:0060620 | regulation of cholesterol import | 1.787736e-4 |
GO:0090197 | positive regulation of chemokine secretion | 1.831410e-4 |
GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation | 1.831410e-4 |
GO:0072126 | positive regulation of glomerular mesangial cell proliferation | 1.906437e-4 |
GO:0071506 | cellular response to mycophenolic acid | 1.906437e-4 |
GO:0042908 | xenobiotic transport | 1.991714e-4 |
GO:0060670 | branching involved in embryonic placenta morphogenesis | 2.059551e-4 |
GO:0032736 | positive regulation of interleukin-13 production | 2.142473e-4 |
GO:0044027 | hypermethylation of CpG island | 2.184787e-4 |
GO:0022417 | protein maturation by protein folding | 2.222728e-4 |
GO:2000649 | regulation of sodium ion transmembrane transporter activity | 2.314458e-4 |
GO:0034470 | ncRNA processing | 2.315253e-4 |
GO:0019542 | propionate biosynthetic process | 2.354465e-4 |
GO:0019413 | acetate biosynthetic process | 2.354465e-4 |
GO:0018192 | enzyme active site formation via L-cysteine persulfide | 2.354465e-4 |
GO:0015761 | mannose transport | 2.354465e-4 |
GO:0070988 | demethylation | 2.490628e-4 |
GO:0034340 | response to type I interferon | 2.595927e-4 |
GO:0006335 | DNA replication-dependent nucleosome assembly | 2.690316e-4 |
GO:0032782 | bile acid secretion | 2.691948e-4 |
GO:0051208 | sequestering of calcium ion | 2.726669e-4 |
GO:0014819 | regulation of skeletal muscle contraction | 2.726669e-4 |
GO:0046533 | negative regulation of photoreceptor cell differentiation | 2.754812e-4 |
GO:0045604 | regulation of epidermal cell differentiation | 2.984560e-4 |
GO:0046498 | S-adenosylhomocysteine metabolic process | 3.001433e-4 |
GO:0030852 | regulation of granulocyte differentiation | 3.057423e-4 |
GO:0007538 | primary sex determination | 3.077987e-4 |
GO:0032203 | telomere formation via telomerase | 3.094015e-4 |
GO:0071340 | skeletal muscle nicotinic acetylcholine receptor clustering | 3.240264e-4 |
GO:0006826 | iron ion transport | 3.372793e-4 |
GO:0072303 | positive regulation of glomerular metanephric mesangial cell proliferation | 3.425862e-4 |
GO:0060084 | synaptic transmission involved in micturition | 3.483738e-4 |
GO:0061037 | negative regulation of cartilage development | 3.502470e-4 |
GO:0006617 | SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition | 3.630285e-4 |
GO:0006616 | SRP-dependent cotranslational protein targeting to membrane, translocation | 3.630285e-4 |
GO:0032938 | negative regulation of translation in response to oxidative stress | 3.662719e-4 |
GO:0031591 | wybutosine biosynthetic process | 3.662719e-4 |
GO:0010616 | negative regulation of cardiac muscle adaptation | 3.728131e-4 |
GO:0009098 | leucine biosynthetic process | 3.728131e-4 |
GO:0006550 | isoleucine catabolic process | 3.728131e-4 |
GO:0006754 | ATP biosynthetic process | 3.839105e-4 |
GO:0034442 | regulation of lipoprotein oxidation | 3.839985e-4 |
GO:0034227 | tRNA thio-modification | 3.839985e-4 |
GO:0002098 | tRNA wobble uridine modification | 3.839985e-4 |
GO:0006990 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response | 3.975036e-4 |
GO:0042481 | regulation of odontogenesis | 4.062652e-4 |
GO:0046292 | formaldehyde metabolic process | 4.064766e-4 |
GO:0030573 | bile acid catabolic process | 4.064766e-4 |
GO:0035039 | male pronucleus assembly | 4.095546e-4 |
GO:0045814 | negative regulation of gene expression, epigenetic | 4.099138e-4 |
GO:0002636 | positive regulation of germinal center formation | 4.132375e-4 |
GO:0006694 | steroid biosynthetic process | 4.145332e-4 |
GO:0035854 | eosinophil fate commitment | 4.530202e-4 |
GO:0030222 | eosinophil differentiation | 4.530202e-4 |
GO:0071353 | cellular response to interleukin-4 | 4.570064e-4 |
GO:0035552 | oxidative single-stranded DNA demethylation | 4.619234e-4 |
GO:0060337 | type I interferon-mediated signaling pathway | 4.643556e-4 |
GO:0060455 | negative regulation of gastric acid secretion | 4.891728e-4 |
GO:0060381 | positive regulation of single-stranded telomeric DNA binding | 4.891728e-4 |
GO:0007063 | regulation of sister chromatid cohesion | 4.908756e-4 |
GO:0046474 | glycerophospholipid biosynthetic process | 5.027539e-4 |
GO:0042218 | 1-aminocyclopropane-1-carboxylate biosynthetic process | 5.028092e-4 |
GO:0032055 | negative regulation of translation in response to stress | 5.345354e-4 |
GO:0010452 | histone H3-K36 methylation | 5.402399e-4 |
GO:0030300 | regulation of intestinal cholesterol absorption | 5.637678e-4 |
GO:0051972 | regulation of telomerase activity | 5.657310e-4 |
GO:0060706 | cell differentiation involved in embryonic placenta development | 5.746913e-4 |
GO:0070670 | response to interleukin-4 | 5.820041e-4 |
GO:0032312 | regulation of ARF GTPase activity | 5.946027e-4 |
GO:0015746 | citrate transport | 6.184724e-4 |
GO:0061103 | carotid body glomus cell differentiation | 6.294792e-4 |
GO:0061104 | adrenal chromaffin cell differentiation | 6.294792e-4 |
GO:0061102 | stomach neuroendocrine cell differentiation | 6.294792e-4 |
GO:0071259 | cellular response to magnetism | 6.294792e-4 |
GO:0061100 | lung neuroendocrine cell differentiation | 6.294792e-4 |
GO:0007400 | neuroblast fate determination | 6.294792e-4 |
GO:0003359 | noradrenergic neuron fate commitment | 6.294792e-4 |
GO:0060163 | subpallium neuron fate commitment | 6.294792e-4 |
GO:0060165 | regulation of timing of subpallium neuron differentiation | 6.294792e-4 |
GO:0007028 | cytoplasm organization | 6.307543e-4 |
GO:0035814 | negative regulation of renal sodium excretion | 7.071318e-4 |
GO:0060299 | negative regulation of sarcomere organization | 7.547701e-4 |
GO:0033292 | T-tubule organization | 7.547701e-4 |
GO:0048790 | maintenance of presynaptic active zone structure | 7.622114e-4 |
GO:0031630 | regulation of synaptic vesicle fusion to presynaptic membrane | 7.622114e-4 |
GO:0022613 | ribonucleoprotein complex biogenesis | 7.639613e-4 |
GO:0070170 | regulation of tooth mineralization | 8.348510e-4 |
GO:0010988 | regulation of low-density lipoprotein particle clearance | 8.450114e-4 |
GO:0015884 | folic acid transport | 8.465422e-4 |
GO:0072298 | regulation of metanephric glomerulus development | 8.765947e-4 |
GO:0032057 | negative regulation of translational initiation in response to stress | 8.829319e-4 |
GO:0045835 | negative regulation of meiosis | 9.176457e-4 |
GO:0070849 | response to epidermal growth factor stimulus | 9.205172e-4 |
GO:0045358 | negative regulation of interferon-beta biosynthetic process | 9.475335e-4 |
GO:0090084 | negative regulation of inclusion body assembly | 9.507454e-4 |
GO:0032415 | regulation of sodium:hydrogen antiporter activity | 9.566142e-4 |
GO:0042791 | 5S class rRNA transcription from RNA polymerase III type 1 promoter | 9.800442e-4 |
GO:0042797 | tRNA transcription from RNA polymerase III promoter | 9.800442e-4 |
GO:0070483 | detection of hypoxia | 9.887079e-4 |
GO:0010989 | negative regulation of low-density lipoprotein particle clearance | 9.892181e-4 |
GO:0071843 | cellular component biogenesis at cellular level | 1.021315e-3 |
GO:0000084 | S phase of mitotic cell cycle | 1.055772e-3 |
GO:0043461 | proton-transporting ATP synthase complex assembly | 1.080083e-3 |
GO:0022415 | viral reproductive process | 1.082600e-3 |
GO:0006501 | C-terminal protein lipidation | 1.107726e-3 |
GO:0006704 | glucocorticoid biosynthetic process | 1.140861e-3 |
GO:0048873 | homeostasis of number of cells within a tissue | 1.167231e-3 |
GO:0006458 | 'de novo' protein folding | 1.200153e-3 |
GO:0046778 | modification by virus of host mRNA processing | 1.213570e-3 |
GO:0030046 | parallel actin filament bundle assembly | 1.213570e-3 |
GO:0032200 | telomere organization | 1.232905e-3 |
GO:0003417 | growth plate cartilage development | 1.238371e-3 |
GO:0033153 | T cell receptor V(D)J recombination | 1.264009e-3 |
GO:0002033 | vasodilation by angiotensin involved in regulation of systemic arterial blood pressure | 1.291452e-3 |
GO:0031118 | rRNA pseudouridine synthesis | 1.297104e-3 |
GO:0023035 | CD40 signaling pathway | 1.297104e-3 |
GO:0072302 | negative regulation of metanephric glomerular mesangial cell proliferation | 1.435424e-3 |
GO:0061032 | visceral serous pericardium development | 1.435424e-3 |
GO:0006342 | chromatin silencing | 1.459575e-3 |
GO:0032674 | regulation of interleukin-5 production | 1.485478e-3 |
GO:0018410 | C-terminal protein amino acid modification | 1.502730e-3 |
GO:0051320 | S phase | 1.526489e-3 |
GO:0007296 | vitellogenesis | 1.540593e-3 |
GO:0060307 | regulation of ventricular cardiomyocyte membrane repolarization | 1.564062e-3 |
GO:2000277 | positive regulation of oxidative phosphorylation uncoupler activity | 1.564062e-3 |
GO:0043418 | homocysteine catabolic process | 1.564062e-3 |
GO:0006535 | cysteine biosynthetic process from serine | 1.564062e-3 |
GO:0019343 | cysteine biosynthetic process via cystathionine | 1.564062e-3 |
GO:0019346 | transsulfuration | 1.564062e-3 |
GO:0048243 | norepinephrine secretion | 1.593860e-3 |
GO:0006835 | dicarboxylic acid transport | 1.604644e-3 |
GO:0003093 | regulation of glomerular filtration | 1.626502e-3 |
GO:0051323 | metaphase | 1.631893e-3 |
GO:0006942 | regulation of striated muscle contraction | 1.651913e-3 |
GO:0035645 | enteric smooth muscle cell differentiation | 1.718117e-3 |
GO:0008272 | sulfate transport | 1.724753e-3 |
GO:0006482 | protein demethylation | 1.727647e-3 |
GO:0051238 | sequestering of metal ion | 1.790033e-3 |
GO:0014741 | negative regulation of muscle hypertrophy | 1.813171e-3 |
GO:0060707 | trophoblast giant cell differentiation | 1.896906e-3 |
GO:0001892 | embryonic placenta development | 1.910411e-3 |
GO:0006621 | protein retention in ER lumen | 1.920157e-3 |
GO:0000724 | double-strand break repair via homologous recombination | 1.935694e-3 |
GO:0051084 | 'de novo' posttranslational protein folding | 1.964065e-3 |
GO:0032416 | negative regulation of sodium:hydrogen antiporter activity | 1.973513e-3 |
GO:0018293 | protein-FAD linkage | 1.973513e-3 |
GO:0006121 | mitochondrial electron transport, succinate to ubiquinone | 1.973513e-3 |
GO:0060351 | cartilage development involved in endochondral bone morphogenesis | 1.973581e-3 |
GO:0009304 | tRNA transcription | 2.015854e-3 |
GO:0072124 | regulation of glomerular mesangial cell proliferation | 2.028250e-3 |
GO:0043928 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 2.030756e-3 |
GO:0010701 | positive regulation of norepinephrine secretion | 2.035754e-3 |
GO:0010172 | embryonic body morphogenesis | 2.119732e-3 |
GO:0034635 | glutathione transport | 2.171107e-3 |
GO:0051344 | negative regulation of cyclic-nucleotide phosphodiesterase activity | 2.171107e-3 |
GO:0019478 | D-amino acid catabolic process | 2.171107e-3 |
GO:0000725 | recombinational repair | 2.189626e-3 |
GO:0031296 | B cell costimulation | 2.303365e-3 |
GO:0022411 | cellular component disassembly | 2.322813e-3 |
GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II | 2.334988e-3 |
GO:0097039 | protein linear polyubiquitination | 2.338619e-3 |
GO:0033599 | regulation of mammary gland epithelial cell proliferation | 2.377873e-3 |
GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process | 2.391237e-3 |
GO:0000730 | DNA recombinase assembly | 2.547861e-3 |
GO:0032796 | uropod organization | 2.565344e-3 |
GO:0072262 | metanephric glomerular mesangial cell proliferation involved in metanephros development | 2.578813e-3 |
GO:0043128 | positive regulation of 1-phosphatidylinositol 4-kinase activity | 2.578813e-3 |
GO:0071670 | smooth muscle cell chemotaxis | 2.668162e-3 |
GO:0060981 | cell migration involved in coronary angiogenesis | 2.668162e-3 |
GO:0090346 | cellular organofluorine metabolic process | 2.668162e-3 |
GO:0046210 | nitric oxide catabolic process | 2.668162e-3 |
GO:0060764 | cell-cell signaling involved in mammary gland development | 2.668162e-3 |
GO:0043602 | nitrate catabolic process | 2.668162e-3 |
GO:0046294 | formaldehyde catabolic process | 2.668162e-3 |
GO:0048692 | negative regulation of axon extension involved in regeneration | 2.717088e-3 |
GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly | 2.800553e-3 |
GO:0032780 | negative regulation of ATPase activity | 2.809466e-3 |
GO:0071347 | cellular response to interleukin-1 | 2.820139e-3 |
GO:0030490 | maturation of SSU-rRNA | 2.851661e-3 |
GO:2000195 | negative regulation of female gonad development | 2.935970e-3 |
GO:0006348 | chromatin silencing at telomere | 2.954248e-3 |
GO:0072329 | monocarboxylic acid catabolic process | 2.962006e-3 |
GO:0045630 | positive regulation of T-helper 2 cell differentiation | 2.972008e-3 |
GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I | 2.995896e-3 |
GO:0016926 | protein desumoylation | 2.995896e-3 |
GO:0042267 | natural killer cell mediated cytotoxicity | 3.016357e-3 |
GO:0016577 | histone demethylation | 3.092331e-3 |
GO:0006598 | polyamine catabolic process | 3.098429e-3 |
GO:0002158 | osteoclast proliferation | 3.098429e-3 |
GO:0002762 | negative regulation of myeloid leukocyte differentiation | 3.130739e-3 |
GO:0009152 | purine ribonucleotide biosynthetic process | 3.133189e-3 |
GO:0003071 | renal system process involved in regulation of systemic arterial blood pressure | 3.151434e-3 |
GO:0021548 | pons development | 3.186994e-3 |
GO:0031444 | slow-twitch skeletal muscle fiber contraction | 3.191864e-3 |
GO:0007497 | posterior midgut development | 3.256181e-3 |
GO:0060087 | relaxation of vascular smooth muscle | 3.258886e-3 |
GO:0071044 | histone mRNA catabolic process | 3.341759e-3 |
GO:0021588 | cerebellum formation | 3.377332e-3 |
GO:0022004 | midbrain-hindbrain boundary maturation during brain development | 3.377332e-3 |
GO:2000002 | negative regulation of DNA damage checkpoint | 3.377332e-3 |
GO:0021551 | central nervous system morphogenesis | 3.377332e-3 |
GO:0002082 | regulation of oxidative phosphorylation | 3.377332e-3 |
GO:0003106 | negative regulation of glomerular filtration by angiotensin | 3.377332e-3 |
GO:0006843 | mitochondrial citrate transport | 3.377332e-3 |
GO:0014895 | smooth muscle hypertrophy | 3.377332e-3 |
GO:0042274 | ribosomal small subunit biogenesis | 3.520625e-3 |
GO:0016264 | gap junction assembly | 3.543587e-3 |
GO:0030212 | hyaluronan metabolic process | 3.586385e-3 |
GO:0006266 | DNA ligation | 3.593689e-3 |
GO:2000194 | regulation of female gonad development | 3.631775e-3 |
GO:0006307 | DNA dealkylation involved in DNA repair | 3.719888e-3 |
GO:0072332 | signal transduction by p53 class mediator resulting in induction of apoptosis | 3.729719e-3 |
GO:0006306 | DNA methylation | 3.764740e-3 |
GO:0008052 | sensory organ boundary specification | 3.813203e-3 |
GO:0003416 | endochondral bone growth | 3.910423e-3 |
GO:0032020 | ISG15-protein conjugation | 3.965098e-3 |
GO:0033235 | positive regulation of protein sumoylation | 3.973453e-3 |
GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin | 3.978308e-3 |
GO:0060049 | regulation of protein glycosylation | 4.081590e-3 |
GO:0071315 | cellular response to morphine | 4.089599e-3 |
GO:0071307 | cellular response to vitamin K | 4.089599e-3 |
GO:0090324 | negative regulation of oxidative phosphorylation | 4.089599e-3 |
GO:0071448 | cellular response to alkyl hydroperoxide | 4.089599e-3 |
GO:0071403 | cellular response to high density lipoprotein particle stimulus | 4.089599e-3 |
GO:0050904 | diapedesis | 4.089599e-3 |
GO:0031269 | pseudopodium assembly | 4.089599e-3 |
GO:0010255 | glucose mediated signaling pathway | 4.089599e-3 |
GO:0032900 | negative regulation of neurotrophin production | 4.089599e-3 |
GO:0032244 | positive regulation of nucleoside transport | 4.089599e-3 |
GO:0016233 | telomere capping | 4.157213e-3 |
GO:0071845 | cellular component disassembly at cellular level | 4.215186e-3 |
GO:0019062 | virion attachment to host cell surface receptor | 4.247068e-3 |
GO:0070344 | regulation of fat cell proliferation | 4.338849e-3 |
GO:0035511 | oxidative DNA demethylation | 4.339505e-3 |
GO:0045747 | positive regulation of Notch signaling pathway | 4.341364e-3 |
GO:0045616 | regulation of keratinocyte differentiation | 4.479012e-3 |
GO:0019884 | antigen processing and presentation of exogenous antigen | 4.485979e-3 |
GO:0045872 | positive regulation of rhodopsin gene expression | 4.507969e-3 |
GO:0006467 | protein thiol-disulfide exchange | 4.522184e-3 |
GO:0007386 | compartment pattern specification | 4.656177e-3 |
GO:0051775 | response to redox state | 4.686380e-3 |
GO:0043462 | regulation of ATPase activity | 4.703821e-3 |
GO:0035573 | N-terminal peptidyl-serine trimethylation | 4.705927e-3 |
GO:0035572 | N-terminal peptidyl-serine dimethylation | 4.705927e-3 |
GO:0018016 | N-terminal peptidyl-proline dimethylation | 4.705927e-3 |
GO:0018012 | N-terminal peptidyl-alanine trimethylation | 4.705927e-3 |
GO:0000089 | mitotic metaphase | 4.756891e-3 |
GO:0009119 | ribonucleoside metabolic process | 4.807835e-3 |
GO:0016139 | glycoside catabolic process | 4.917253e-3 |
GO:0021506 | anterior neuropore closure | 4.917253e-3 |
GO:0034384 | high-density lipoprotein particle clearance | 5.037299e-3 |
GO:0009148 | pyrimidine nucleoside triphosphate biosynthetic process | 5.065513e-3 |
GO:0045006 | DNA deamination | 5.067875e-3 |
GO:0045820 | negative regulation of glycolysis | 5.116025e-3 |
GO:0006684 | sphingomyelin metabolic process | 5.119960e-3 |
GO:0006661 | phosphatidylinositol biosynthetic process | 5.184000e-3 |
GO:0031952 | regulation of protein autophosphorylation | 5.206330e-3 |
GO:0006635 | fatty acid beta-oxidation | 5.209225e-3 |
GO:0018198 | peptidyl-cysteine modification | 5.262404e-3 |
GO:0060051 | negative regulation of protein glycosylation | 5.326132e-3 |
GO:0060716 | labyrinthine layer blood vessel development | 5.348521e-3 |
GO:0051343 | positive regulation of cyclic-nucleotide phosphodiesterase activity | 5.428176e-3 |
GO:0032074 | negative regulation of nuclease activity | 5.428176e-3 |
GO:0031627 | telomeric loop formation | 5.428176e-3 |
GO:0015074 | DNA integration | 5.483872e-3 |
GO:0007620 | copulation | 5.552017e-3 |
GO:2000117 | negative regulation of cysteine-type endopeptidase activity | 5.612787e-3 |
GO:0048298 | positive regulation of isotype switching to IgA isotypes | 5.615475e-3 |
GO:0070328 | triglyceride homeostasis | 5.618922e-3 |
GO:0050435 | beta-amyloid metabolic process | 5.646733e-3 |
GO:0010536 | positive regulation of activation of Janus kinase activity | 5.679447e-3 |
GO:0046314 | phosphocreatine biosynthetic process | 5.697239e-3 |
GO:0048733 | sebaceous gland development | 5.804400e-3 |
GO:0014807 | regulation of somitogenesis | 5.804400e-3 |
GO:0001881 | receptor recycling | 5.804400e-3 |
GO:0010841 | positive regulation of circadian sleep/wake cycle, wakefulness | 5.804400e-3 |
GO:0046813 | virion attachment, binding of host cell surface receptor | 5.812649e-3 |
GO:0002250 | adaptive immune response | 5.873992e-3 |
GO:0018206 | peptidyl-methionine modification | 5.916115e-3 |
GO:0006651 | diacylglycerol biosynthetic process | 5.952925e-3 |
GO:0008215 | spermine metabolic process | 5.961623e-3 |
GO:0010901 | regulation of very-low-density lipoprotein particle remodeling | 6.035673e-3 |
GO:0048632 | negative regulation of skeletal muscle tissue growth | 6.114394e-3 |
GO:0002017 | regulation of blood volume by renal aldosterone | 6.114394e-3 |
GO:0090230 | regulation of centromere complex assembly | 6.157825e-3 |
GO:0034205 | beta-amyloid formation | 6.157825e-3 |
GO:0035308 | negative regulation of protein dephosphorylation | 6.290322e-3 |
GO:0071356 | cellular response to tumor necrosis factor | 6.315598e-3 |
GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 6.346029e-3 |
GO:0033144 | negative regulation of steroid hormone receptor signaling pathway | 6.375780e-3 |
GO:0002495 | antigen processing and presentation of peptide antigen via MHC class II | 6.381571e-3 |
GO:0001974 | blood vessel remodeling | 6.488999e-3 |
GO:0045343 | regulation of MHC class I biosynthetic process | 6.526130e-3 |
GO:0032656 | regulation of interleukin-13 production | 6.605997e-3 |
GO:0018393 | internal peptidyl-lysine acetylation | 6.656681e-3 |
GO:0051958 | methotrexate transport | 6.920356e-3 |
GO:0046022 | positive regulation of transcription from RNA polymerase II promoter during mitosis | 6.920356e-3 |
GO:0019388 | galactose catabolic process | 6.920356e-3 |
GO:0010631 | epithelial cell migration | 6.945966e-3 |
GO:0042711 | maternal behavior | 6.998794e-3 |
GO:0050732 | negative regulation of peptidyl-tyrosine phosphorylation | 7.036140e-3 |
GO:0032753 | positive regulation of interleukin-4 production | 7.038035e-3 |
GO:0007184 | SMAD protein import into nucleus | 7.038035e-3 |
GO:0032776 | DNA methylation on cytosine | 7.153712e-3 |
GO:0010626 | negative regulation of Schwann cell proliferation | 7.153712e-3 |
GO:2000016 | negative regulation of determination of dorsal identity | 7.158898e-3 |
GO:0000461 | endonucleolytic cleavage to generate mature 3'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 7.158898e-3 |
GO:0045796 | negative regulation of intestinal cholesterol absorption | 7.158898e-3 |
GO:0032972 | regulation of muscle filament sliding speed | 7.158898e-3 |
GO:0010949 | negative regulation of intestinal phytosterol absorption | 7.158898e-3 |
GO:0060784 | regulation of cell proliferation involved in tissue homeostasis | 7.162496e-3 |
GO:2000138 | positive regulation of cell proliferation involved in heart morphogenesis | 7.162496e-3 |
GO:0060517 | epithelial cell proliferation involved in prostatic bud elongation | 7.162496e-3 |
GO:0035622 | intrahepatic bile duct development | 7.162496e-3 |
GO:0003415 | chondrocyte hypertrophy | 7.162496e-3 |
GO:0019100 | male germ-line sex determination | 7.162496e-3 |
GO:0002467 | germinal center formation | 7.271893e-3 |
GO:0035364 | thymine transport | 7.296285e-3 |
GO:0035344 | hypoxanthine transport | 7.296285e-3 |
GO:0031658 | negative regulation of cyclin-dependent protein kinase activity involved in G1/S | 7.296285e-3 |
GO:0007092 | activation of mitotic anaphase-promoting complex activity | 7.296285e-3 |
GO:0015854 | guanine transport | 7.296285e-3 |
GO:0033687 | osteoblast proliferation | 7.339658e-3 |
GO:0010903 | negative regulation of very-low-density lipoprotein particle remodeling | 7.339658e-3 |
GO:0000072 | M phase specific microtubule process | 7.358768e-3 |
GO:0072011 | glomerular endothelium development | 7.366295e-3 |
GO:0072144 | glomerular mesangial cell development | 7.366295e-3 |
GO:0007192 | activation of adenylate cyclase activity by serotonin receptor signaling pathway | 7.366295e-3 |
GO:0001980 | regulation of systemic arterial blood pressure by ischemic conditions | 7.366295e-3 |
GO:0010529 | negative regulation of transposition | 7.391657e-3 |
GO:0031998 | regulation of fatty acid beta-oxidation | 7.478561e-3 |
GO:0001909 | leukocyte mediated cytotoxicity | 7.553748e-3 |
GO:0006346 | methylation-dependent chromatin silencing | 7.582820e-3 |
GO:0000413 | protein peptidyl-prolyl isomerization | 7.585817e-3 |
GO:0030382 | sperm mitochondrion organization | 7.602176e-3 |
GO:0032269 | negative regulation of cellular protein metabolic process | 7.746889e-3 |
GO:0002063 | chondrocyte development | 7.813118e-3 |
GO:0090192 | regulation of glomerulus development | 7.844081e-3 |
GO:0048821 | erythrocyte development | 7.903137e-3 |
GO:0018394 | peptidyl-lysine acetylation | 7.918965e-3 |
GO:0043046 | DNA methylation involved in gamete generation | 7.934977e-3 |
GO:0051365 | cellular response to potassium ion starvation | 7.937910e-3 |
GO:0009642 | response to light intensity | 7.937910e-3 |
GO:0006097 | glyoxylate cycle | 7.937910e-3 |
GO:0045759 | negative regulation of action potential | 8.070217e-3 |
GO:0090141 | positive regulation of mitochondrial fission | 8.093417e-3 |
GO:0070345 | negative regulation of fat cell proliferation | 8.093417e-3 |
GO:0030206 | chondroitin sulfate biosynthetic process | 8.188882e-3 |
GO:0006032 | chitin catabolic process | 8.470275e-3 |
GO:0051292 | nuclear pore complex assembly | 8.511327e-3 |
GO:0010712 | regulation of collagen metabolic process | 8.578640e-3 |
GO:0072529 | pyrimidine-containing compound catabolic process | 8.578640e-3 |
GO:0030238 | male sex determination | 8.602432e-3 |
GO:0006885 | regulation of pH | 8.724321e-3 |
GO:0070474 | positive regulation of uterine smooth muscle contraction | 8.764675e-3 |
GO:0009260 | ribonucleotide biosynthetic process | 8.916181e-3 |
GO:0015893 | drug transport | 9.023660e-3 |
GO:0022009 | central nervous system vasculogenesis | 9.234659e-3 |
GO:0006475 | internal protein amino acid acetylation | 9.326525e-3 |
GO:0033600 | negative regulation of mammary gland epithelial cell proliferation | 9.364008e-3 |
GO:0009698 | phenylpropanoid metabolic process | 9.418863e-3 |
GO:0019448 | L-cysteine catabolic process | 9.511699e-3 |
GO:0070071 | proton-transporting two-sector ATPase complex assembly | 9.518914e-3 |
GO:0032965 | regulation of collagen biosynthetic process | 9.525750e-3 |
GO:0043304 | regulation of mast cell degranulation | 9.606550e-3 |
GO:0016071 | mRNA metabolic process | 9.642199e-3 |
GO:0030277 | maintenance of gastrointestinal epithelium | 9.666052e-3 |
GO:0019061 | uncoating of virus | 9.685892e-3 |
GO:0045626 | negative regulation of T-helper 1 cell differentiation | 9.814759e-3 |
GO:0006308 | DNA catabolic process | 9.914489e-3 |
GO:0035545 | determination of left/right asymmetry in nervous system | 9.922299e-3 |
GO:0007021 | tubulin complex assembly | 9.981973e-3 |
GO:0001782 | B cell homeostasis | 1.001376e-2 |
GO:0010522 | regulation of calcium ion transport into cytosol | 1.003900e-2 |
GO:0015891 | siderophore transport | 1.013409e-2 |
GO:0061014 | positive regulation of mRNA catabolic process | 1.013768e-2 |
GO:0006544 | glycine metabolic process | 1.028953e-2 |
GO:0070734 | histone H3-K27 methylation | 1.042423e-2 |
GO:0006720 | isoprenoid metabolic process | 1.043042e-2 |
GO:0043543 | protein acylation | 1.044154e-2 |
GO:0060213 | positive regulation of nuclear-transcribed mRNA poly(A) tail shortening | 1.060550e-2 |
GO:0030220 | platelet formation | 1.060999e-2 |
GO:0044338 | canonical Wnt receptor signaling pathway involved in mesenchymal stem cell differentiation | 1.066391e-2 |
GO:0044339 | canonical Wnt receptor signaling pathway involved in osteoblast differentiation | 1.066391e-2 |
GO:0072166 | posterior mesonephric tubule development | 1.067368e-2 |
GO:0033057 | multicellular organismal reproductive behavior | 1.071187e-2 |
GO:0007597 | blood coagulation, intrinsic pathway | 1.078643e-2 |
GO:0010624 | regulation of Schwann cell proliferation | 1.080873e-2 |
GO:0015874 | norepinephrine transport | 1.086805e-2 |
GO:0010982 | regulation of high-density lipoprotein particle clearance | 1.098937e-2 |
GO:0051593 | response to folic acid | 1.126703e-2 |
GO:0048205 | COPI coating of Golgi vesicle | 1.128428e-2 |
GO:0090344 | negative regulation of cell aging | 1.140022e-2 |
GO:0006228 | UTP biosynthetic process | 1.140127e-2 |
GO:0006165 | nucleoside diphosphate phosphorylation | 1.140127e-2 |
GO:0006183 | GTP biosynthetic process | 1.140127e-2 |
GO:0061383 | trabecula morphogenesis | 1.147239e-2 |
GO:0050667 | homocysteine metabolic process | 1.149787e-2 |
GO:0006596 | polyamine biosynthetic process | 1.152812e-2 |
GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity | 1.153932e-2 |
GO:0016032 | viral reproduction | 1.168810e-2 |
GO:0008535 | respiratory chain complex IV assembly | 1.168923e-2 |
GO:0009116 | nucleoside metabolic process | 1.186694e-2 |
GO:0018924 | mandelate metabolic process | 1.188913e-2 |
GO:0006309 | DNA fragmentation involved in apoptotic nuclear change | 1.189917e-2 |
GREAT analysis results for mouseGenomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon <br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0048298 | positive regulation of isotype switching to IgA isotypes | 5.087187e-16 |
GO:0090031 | positive regulation of steroid hormone biosynthetic process | 2.832160e-12 |
GO:0035094 | response to nicotine | 7.982866e-12 |
GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase cascade | 1.020642e-11 |
GO:0010893 | positive regulation of steroid biosynthetic process | 1.601122e-11 |
GO:0046886 | positive regulation of hormone biosynthetic process | 1.966811e-10 |
GO:0046628 | positive regulation of insulin receptor signaling pathway | 4.093426e-10 |
GO:0090030 | regulation of steroid hormone biosynthetic process | 2.772941e-9 |
GO:2000343 | positive regulation of chemokine (C-X-C motif) ligand 2 production | 2.944956e-9 |
GO:0002636 | positive regulation of germinal center formation | 5.262165e-9 |
GO:2000467 | positive regulation of glycogen (starch) synthase activity | 9.578403e-9 |
GO:0045980 | negative regulation of nucleotide metabolic process | 9.833822e-9 |
GO:0046889 | positive regulation of lipid biosynthetic process | 1.770414e-8 |
GO:0035691 | macrophage migration inhibitory factor signaling pathway | 1.863664e-8 |
GO:0030818 | negative regulation of cAMP biosynthetic process | 3.882423e-8 |
GO:0051897 | positive regulation of protein kinase B signaling cascade | 5.526059e-8 |
GO:0032352 | positive regulation of hormone metabolic process | 5.832364e-8 |
GO:2000465 | regulation of glycogen (starch) synthase activity | 7.200082e-8 |
GO:0048240 | sperm capacitation | 8.409858e-8 |
GO:0051085 | chaperone mediated protein folding requiring cofactor | 1.231205e-7 |
GO:0019730 | antimicrobial humoral response | 1.619595e-7 |
GO:0006693 | prostaglandin metabolic process | 2.154956e-7 |
GO:0070228 | regulation of lymphocyte apoptosis | 2.934126e-7 |
GO:0046885 | regulation of hormone biosynthetic process | 5.093592e-7 |
GO:0001516 | prostaglandin biosynthetic process | 5.315458e-7 |
GO:0010935 | regulation of macrophage cytokine production | 6.769577e-7 |
GO:0042790 | transcription of nuclear large rRNA transcript from RNA polymerase I promoter | 7.438149e-7 |
GO:0002606 | positive regulation of dendritic cell antigen processing and presentation | 8.780937e-7 |
GO:0034505 | tooth mineralization | 1.246377e-6 |
GO:0019731 | antibacterial humoral response | 1.252636e-6 |
GO:0032963 | collagen metabolic process | 1.355870e-6 |
GO:0007586 | digestion | 1.491802e-6 |
GO:0051084 | 'de novo' posttranslational protein folding | 1.522544e-6 |
GO:0044259 | multicellular organismal macromolecule metabolic process | 1.816453e-6 |
GO:0019724 | B cell mediated immunity | 1.855055e-6 |
GO:0060346 | bone trabecula formation | 2.068554e-6 |
GO:0002830 | positive regulation of type 2 immune response | 2.118199e-6 |
GO:0007288 | sperm axoneme assembly | 2.260931e-6 |
GO:0016064 | immunoglobulin mediated immune response | 2.977164e-6 |
GO:0044236 | multicellular organismal metabolic process | 3.713152e-6 |
GO:0090083 | regulation of inclusion body assembly | 3.856586e-6 |
GO:0070230 | positive regulation of lymphocyte apoptosis | 4.287194e-6 |
GO:0060674 | placenta blood vessel development | 4.484765e-6 |
GO:0051896 | regulation of protein kinase B signaling cascade | 5.882862e-6 |
GO:0002604 | regulation of dendritic cell antigen processing and presentation | 6.362905e-6 |
GO:0030307 | positive regulation of cell growth | 7.036806e-6 |
GO:0042104 | positive regulation of activated T cell proliferation | 7.538574e-6 |
GO:0045725 | positive regulation of glycogen biosynthetic process | 7.828713e-6 |
GO:0070232 | regulation of T cell apoptosis | 9.465540e-6 |
GO:2000273 | positive regulation of receptor activity | 9.836997e-6 |
GO:0031999 | negative regulation of fatty acid beta-oxidation | 1.079946e-5 |
GO:0045940 | positive regulation of steroid metabolic process | 1.616714e-5 |
GO:0045796 | negative regulation of intestinal cholesterol absorption | 1.657591e-5 |
GO:0010949 | negative regulation of intestinal phytosterol absorption | 1.657591e-5 |
GO:0009817 | defense response to fungus, incompatible interaction | 1.657591e-5 |
GO:0070234 | positive regulation of T cell apoptosis | 1.763477e-5 |
GO:0001957 | intramembranous ossification | 1.860685e-5 |
GO:0070243 | regulation of thymocyte apoptosis | 2.185849e-5 |
GO:0015816 | glycine transport | 2.275274e-5 |
GO:0060711 | labyrinthine layer development | 2.472393e-5 |
GO:0035082 | axoneme assembly | 2.616283e-5 |
GO:0032094 | response to food | 3.072929e-5 |
GO:0031017 | exocrine pancreas development | 3.102518e-5 |
GO:0045908 | negative regulation of vasodilation | 3.376311e-5 |
GO:0006668 | sphinganine-1-phosphate metabolic process | 3.466634e-5 |
GO:0071874 | cellular response to norepinephrine stimulus | 3.484939e-5 |
GO:0007286 | spermatid development | 3.912867e-5 |
GO:0030574 | collagen catabolic process | 4.344949e-5 |
GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator | 4.402829e-5 |
GO:0046006 | regulation of activated T cell proliferation | 4.460900e-5 |
GO:0061081 | positive regulation of myeloid leukocyte cytokine production involved in immune response | 5.548651e-5 |
GO:0060631 | regulation of meiosis I | 5.651208e-5 |
GO:0010520 | regulation of reciprocal meiotic recombination | 5.847401e-5 |
GO:0014910 | regulation of smooth muscle cell migration | 6.618133e-5 |
GO:0070245 | positive regulation of thymocyte apoptosis | 6.923150e-5 |
GO:0060716 | labyrinthine layer blood vessel development | 7.194576e-5 |
GO:0002579 | positive regulation of antigen processing and presentation | 7.270266e-5 |
GO:0016140 | O-glycoside metabolic process | 7.346788e-5 |
GO:0060907 | positive regulation of macrophage cytokine production | 7.451195e-5 |
GO:0031536 | positive regulation of exit from mitosis | 7.484248e-5 |
GO:0019885 | antigen processing and presentation of endogenous peptide antigen via MHC class I | 8.107485e-5 |
GO:0090023 | positive regulation of neutrophil chemotaxis | 8.518011e-5 |
GO:0001553 | luteinization | 8.518011e-5 |
GO:0045581 | negative regulation of T cell differentiation | 8.704385e-5 |
GO:0006360 | transcription from RNA polymerase I promoter | 8.730454e-5 |
GO:0001961 | positive regulation of cytokine-mediated signaling pathway | 9.286319e-5 |
GO:0002906 | negative regulation of mature B cell apoptosis | 9.587299e-5 |
GO:0044243 | multicellular organismal catabolic process | 9.867483e-5 |
GO:2000107 | negative regulation of leukocyte apoptosis | 1.044622e-4 |
GO:0002577 | regulation of antigen processing and presentation | 1.099044e-4 |
GO:0090086 | negative regulation of protein deubiquitination | 1.121701e-4 |
GO:0010718 | positive regulation of epithelial to mesenchymal transition | 1.196099e-4 |
GO:0071340 | skeletal muscle nicotinic acetylcholine receptor clustering | 1.309989e-4 |
GO:0071422 | succinate transmembrane transport | 1.318219e-4 |
GO:0071300 | cellular response to retinoic acid | 1.329918e-4 |
GO:0070229 | negative regulation of lymphocyte apoptosis | 1.342275e-4 |
GO:0046069 | cGMP catabolic process | 1.411290e-4 |
GO:0046314 | phosphocreatine biosynthetic process | 1.494705e-4 |
GO:0043064 | flagellum organization | 1.531971e-4 |
GO:0051973 | positive regulation of telomerase activity | 1.542754e-4 |
GO:0021882 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment | 1.542754e-4 |
GO:0021893 | cerebral cortex GABAergic interneuron fate commitment | 1.542754e-4 |
GO:0060709 | glycogen cell development involved in embryonic placenta development | 1.604968e-4 |
GO:0002426 | immunoglobulin production in mucosal tissue | 1.605537e-4 |
GO:0090022 | regulation of neutrophil chemotaxis | 1.633486e-4 |
GO:2000106 | regulation of leukocyte apoptosis | 1.659346e-4 |
GO:0045834 | positive regulation of lipid metabolic process | 1.683468e-4 |
GO:0021898 | commitment of multipotent stem cells to neuronal lineage in forebrain | 1.730751e-4 |
GO:0046322 | negative regulation of fatty acid oxidation | 1.923584e-4 |
GO:0051904 | pigment granule transport | 2.039145e-4 |
GO:0060323 | head morphogenesis | 2.085607e-4 |
GO:0051781 | positive regulation of cell division | 2.182295e-4 |
GO:0019285 | glycine betaine biosynthetic process from choline | 2.298381e-4 |
GO:0006383 | transcription from RNA polymerase III promoter | 2.298381e-4 |
GO:0046037 | GMP metabolic process | 2.345513e-4 |
GO:0071299 | cellular response to vitamin A | 2.372774e-4 |
GO:0050810 | regulation of steroid biosynthetic process | 2.501938e-4 |
GO:0009296 | flagellum assembly | 2.577540e-4 |
GO:0006513 | protein monoubiquitination | 2.644372e-4 |
GO:0060325 | face morphogenesis | 2.827508e-4 |
GO:0032402 | melanosome transport | 2.857296e-4 |
GO:0072428 | signal transduction involved in intra-S DNA damage checkpoint | 2.862118e-4 |
GO:0043516 | regulation of DNA damage response, signal transduction by p53 class mediator | 2.930537e-4 |
GO:0010025 | wax biosynthetic process | 2.940719e-4 |
GO:0006669 | sphinganine-1-phosphate biosynthetic process | 3.027047e-4 |
GO:0002513 | tolerance induction to self antigen | 3.039571e-4 |
GO:0033523 | histone H2B ubiquitination | 3.222858e-4 |
GO:0001867 | complement activation, lectin pathway | 3.379617e-4 |
GO:0048515 | spermatid differentiation | 3.400656e-4 |
GO:0051444 | negative regulation of ubiquitin-protein ligase activity | 3.571447e-4 |
GO:2001021 | negative regulation of response to DNA damage stimulus | 3.593184e-4 |
GO:0002483 | antigen processing and presentation of endogenous peptide antigen | 3.793385e-4 |
GO:0016480 | negative regulation of transcription from RNA polymerase III promoter | 3.812224e-4 |
GO:0031848 | protection from non-homologous end joining at telomere | 3.812224e-4 |
GO:0006438 | valyl-tRNA aminoacylation | 3.812224e-4 |
GO:0031573 | intra-S DNA damage checkpoint | 3.815510e-4 |
GO:0048016 | inositol phosphate-mediated signaling | 3.822486e-4 |
GO:0043154 | negative regulation of caspase activity | 3.843359e-4 |
GO:0010770 | positive regulation of cell morphogenesis involved in differentiation | 4.058764e-4 |
GO:0001578 | microtubule bundle formation | 4.085072e-4 |
GO:0002455 | humoral immune response mediated by circulating immunoglobulin | 4.158344e-4 |
GO:0046755 | non-lytic virus budding | 4.317027e-4 |
GO:0006354 | transcription elongation, DNA-dependent | 4.347226e-4 |
GO:0060760 | positive regulation of response to cytokine stimulus | 4.445904e-4 |
GO:2000147 | positive regulation of cell motility | 4.499605e-4 |
GO:0048936 | peripheral nervous system neuron axonogenesis | 4.557367e-4 |
GO:0006780 | uroporphyrinogen III biosynthetic process | 4.557367e-4 |
GO:0017196 | N-terminal peptidyl-methionine acetylation | 4.557367e-4 |
GO:0010803 | regulation of tumor necrosis factor-mediated signaling pathway | 4.592395e-4 |
GO:0072376 | protein activation cascade | 4.741719e-4 |
GO:0007200 | activation of phospholipase C activity by G-protein coupled receptor protein signaling pathway coupled to IP3 second messenger | 4.782728e-4 |
GO:0018158 | protein oxidation | 4.856016e-4 |
GO:0006208 | pyrimidine base catabolic process | 5.008337e-4 |
GO:0030050 | vesicle transport along actin filament | 5.420241e-4 |
GO:0045780 | positive regulation of bone resorption | 5.462560e-4 |
GO:0008286 | insulin receptor signaling pathway | 5.473921e-4 |
GO:0030335 | positive regulation of cell migration | 5.809391e-4 |
GO:0040017 | positive regulation of locomotion | 5.928995e-4 |
GO:0006412 | translation | 6.119665e-4 |
GO:0048631 | regulation of skeletal muscle tissue growth | 6.293354e-4 |
GO:0060457 | negative regulation of digestive system process | 6.293354e-4 |
GO:0042886 | amide transport | 6.346707e-4 |
GO:0032350 | regulation of hormone metabolic process | 6.348546e-4 |
GO:0010907 | positive regulation of glucose metabolic process | 6.455581e-4 |
GO:0045907 | positive regulation of vasoconstriction | 6.609338e-4 |
GO:0010225 | response to UV-C | 6.677649e-4 |
GO:0060947 | cardiac vascular smooth muscle cell differentiation | 6.689362e-4 |
GO:0090084 | negative regulation of inclusion body assembly | 6.830273e-4 |
GO:0016485 | protein processing | 6.856675e-4 |
GO:0044029 | hypomethylation of CpG island | 6.971113e-4 |
GO:0043932 | ossification involved in bone remodeling | 6.989482e-4 |
GO:0060547 | negative regulation of necrotic cell death | 7.426251e-4 |
GO:0000738 | DNA catabolic process, exonucleolytic | 7.426251e-4 |
GO:0045124 | regulation of bone resorption | 7.978731e-4 |
GO:0048486 | parasympathetic nervous system development | 8.188963e-4 |
GO:0044341 | sodium-dependent phosphate transport | 8.437374e-4 |
GO:0042663 | regulation of endodermal cell fate specification | 8.437374e-4 |
GO:0070875 | positive regulation of glycogen metabolic process | 8.665000e-4 |
GO:0007096 | regulation of exit from mitosis | 8.841342e-4 |
GO:0019229 | regulation of vasoconstriction | 8.981256e-4 |
GO:0035021 | negative regulation of Rac protein signal transduction | 9.106250e-4 |
GO:0060193 | positive regulation of lipase activity | 9.299956e-4 |
GO:0006368 | transcription elongation from RNA polymerase II promoter | 9.457298e-4 |
GO:0034393 | positive regulation of smooth muscle cell apoptosis | 9.841688e-4 |
GO:0071243 | cellular response to arsenic-containing substance | 9.922644e-4 |
GO:0008634 | negative regulation of survival gene product expression | 9.957534e-4 |
GO:0022614 | membrane to membrane docking | 9.957534e-4 |
GO:0051388 | positive regulation of nerve growth factor receptor signaling pathway | 9.961671e-4 |
GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing | 9.961671e-4 |
GO:0010273 | detoxification of copper ion | 9.961671e-4 |
GO:0006206 | pyrimidine base metabolic process | 1.002421e-3 |
GO:0090179 | planar cell polarity pathway involved in neural tube closure | 1.005819e-3 |
GO:0014912 | negative regulation of smooth muscle cell migration | 1.037893e-3 |
GO:0015840 | urea transport | 1.062037e-3 |
GO:0051604 | protein maturation | 1.100277e-3 |
GO:0033085 | negative regulation of T cell differentiation in thymus | 1.109140e-3 |
GO:0016142 | O-glycoside catabolic process | 1.114979e-3 |
GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation | 1.114979e-3 |
GO:0045620 | negative regulation of lymphocyte differentiation | 1.134920e-3 |
GO:0006378 | mRNA polyadenylation | 1.151650e-3 |
GO:0010390 | histone monoubiquitination | 1.153687e-3 |
GO:0032964 | collagen biosynthetic process | 1.193627e-3 |
GO:0060379 | cardiac muscle cell myoblast differentiation | 1.217087e-3 |
GO:0061077 | chaperone-mediated protein folding | 1.248820e-3 |
GO:0060744 | mammary gland branching involved in thelarche | 1.253402e-3 |
GO:0043279 | response to alkaloid | 1.280017e-3 |
GO:0032233 | positive regulation of actin filament bundle assembly | 1.283499e-3 |
GO:0031124 | mRNA 3'-end processing | 1.296123e-3 |
GO:0060326 | cell chemotaxis | 1.299924e-3 |
GO:0010936 | negative regulation of macrophage cytokine production | 1.308877e-3 |
GO:0006003 | fructose 2,6-bisphosphate metabolic process | 1.309969e-3 |
GO:0006734 | NADH metabolic process | 1.411206e-3 |
GO:0071894 | histone H2B conserved C-terminal lysine ubiquitination | 1.435509e-3 |
GO:0032218 | riboflavin transport | 1.435509e-3 |
GO:0007283 | spermatogenesis | 1.466232e-3 |
GO:0009303 | rRNA transcription | 1.505286e-3 |
GO:0007281 | germ cell development | 1.522891e-3 |
GO:0002903 | negative regulation of B cell apoptosis | 1.537894e-3 |
GO:0060381 | positive regulation of single-stranded telomeric DNA binding | 1.562675e-3 |
GO:0006409 | tRNA export from nucleus | 1.562675e-3 |
GO:0048632 | negative regulation of skeletal muscle tissue growth | 1.562675e-3 |
GO:0018206 | peptidyl-methionine modification | 1.575255e-3 |
GO:0043627 | response to estrogen stimulus | 1.606540e-3 |
GO:0007205 | activation of protein kinase C activity by G-protein coupled receptor protein signaling pathway | 1.606820e-3 |
GO:0002069 | columnar/cuboidal epithelial cell maturation | 1.619109e-3 |
GO:0051905 | establishment of pigment granule localization | 1.681005e-3 |
GO:0035066 | positive regulation of histone acetylation | 1.938136e-3 |
GO:0001558 | regulation of cell growth | 1.938174e-3 |
GO:0048268 | clathrin coat assembly | 1.940725e-3 |
GO:0051272 | positive regulation of cellular component movement | 1.966458e-3 |
GO:0002485 | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent | 1.995956e-3 |
GO:0021783 | preganglionic parasympathetic nervous system development | 1.996058e-3 |
GO:0010660 | regulation of muscle cell apoptosis | 2.015337e-3 |
GO:0002082 | regulation of oxidative phosphorylation | 2.045117e-3 |
GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis | 2.072916e-3 |
GO:0046850 | regulation of bone remodeling | 2.117287e-3 |
GO:0032863 | activation of Rac GTPase activity | 2.145664e-3 |
GO:0006301 | postreplication repair | 2.153671e-3 |
GO:0060351 | cartilage development involved in endochondral bone morphogenesis | 2.160693e-3 |
GO:0042482 | positive regulation of odontogenesis | 2.202736e-3 |
GO:0071257 | cellular response to electrical stimulus | 2.227876e-3 |
GO:0072529 | pyrimidine-containing compound catabolic process | 2.234947e-3 |
GO:0006855 | drug transmembrane transport | 2.275775e-3 |
GO:0032869 | cellular response to insulin stimulus | 2.341783e-3 |
GO:0006901 | vesicle coating | 2.410515e-3 |
GO:0035104 | positive regulation of transcription via sterol regulatory element binding | 2.526187e-3 |
GO:0021542 | dentate gyrus development | 2.570950e-3 |
GO:0002449 | lymphocyte mediated immunity | 2.584034e-3 |
GO:0032241 | positive regulation of nucleobase-containing compound transport | 2.630779e-3 |
GO:0035886 | vascular smooth muscle cell differentiation | 2.657937e-3 |
GO:2000278 | regulation of DNA biosynthetic process | 2.665695e-3 |
GO:0006956 | complement activation | 2.677880e-3 |
GO:0060986 | endocrine hormone secretion | 2.684981e-3 |
GO:0034105 | positive regulation of tissue remodeling | 2.700531e-3 |
GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus | 2.706572e-3 |
GO:0060564 | negative regulation of mitotic anaphase-promoting complex activity | 2.706572e-3 |
GO:0045128 | negative regulation of reciprocal meiotic recombination | 2.706572e-3 |
GO:0006311 | meiotic gene conversion | 2.706572e-3 |
GO:0034337 | RNA folding | 2.793026e-3 |
GO:0032276 | regulation of gonadotropin secretion | 2.812561e-3 |
GO:0035814 | negative regulation of renal sodium excretion | 2.812699e-3 |
GO:0034767 | positive regulation of ion transmembrane transport | 2.863629e-3 |
GO:0031638 | zymogen activation | 2.863629e-3 |
GO:0033604 | negative regulation of catecholamine secretion | 2.881814e-3 |
GO:0010763 | positive regulation of fibroblast migration | 2.881814e-3 |
GO:0032401 | establishment of melanosome localization | 2.903269e-3 |
GO:0090096 | positive regulation of metanephric cap mesenchymal cell proliferation | 2.960677e-3 |
GO:0045773 | positive regulation of axon extension | 3.028020e-3 |
GO:0006878 | cellular copper ion homeostasis | 3.059381e-3 |
GO:0031954 | positive regulation of protein autophosphorylation | 3.065821e-3 |
GO:0050868 | negative regulation of T cell activation | 3.090541e-3 |
GO:0051280 | negative regulation of release of sequestered calcium ion into cytosol | 3.376911e-3 |
GO:0002268 | follicular dendritic cell differentiation | 3.376911e-3 |
GO:0009404 | toxin metabolic process | 3.412777e-3 |
GO:0035793 | positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway | 3.525632e-3 |
GO:0032836 | glomerular basement membrane development | 3.525632e-3 |
GO:0015670 | carbon dioxide transport | 3.525632e-3 |
GO:0006265 | DNA topological change | 3.525632e-3 |
GO:0032642 | regulation of chemokine production | 3.569180e-3 |
GO:0042088 | T-helper 1 type immune response | 3.597678e-3 |
GO:0021563 | glossopharyngeal nerve development | 3.632583e-3 |
GO:0090218 | positive regulation of lipid kinase activity | 3.671492e-3 |
GO:0045927 | positive regulation of growth | 3.689863e-3 |
GO:0060324 | face development | 3.751254e-3 |
GO:0060948 | cardiac vascular smooth muscle cell development | 3.985833e-3 |
GO:0043117 | positive regulation of vascular permeability | 3.985833e-3 |
GO:0033628 | regulation of cell adhesion mediated by integrin | 3.990254e-3 |
GO:0050714 | positive regulation of protein secretion | 4.009314e-3 |
GO:0045988 | negative regulation of striated muscle contraction | 4.083128e-3 |
GO:0014805 | smooth muscle adaptation | 4.126823e-3 |
GO:0035674 | tricarboxylic acid transmembrane transport | 4.126823e-3 |
GO:0009314 | response to radiation | 4.151044e-3 |
GO:0046475 | glycerophospholipid catabolic process | 4.281679e-3 |
GO:0071217 | cellular response to external biotic stimulus | 4.343452e-3 |
GO:0072249 | metanephric glomerular visceral epithelial cell development | 4.343452e-3 |
GO:0072274 | metanephric glomerular basement membrane development | 4.343452e-3 |
GO:0048677 | axon extension involved in regeneration | 4.343452e-3 |
GO:0042700 | luteinizing hormone signaling pathway | 4.343452e-3 |
GO:0017187 | peptidyl-glutamic acid carboxylation | 4.343452e-3 |
GO:0021933 | radial glia guided migration of cerebellar granule cell | 4.343452e-3 |
GO:0002542 | Factor XII activation | 4.343452e-3 |
GO:0032700 | negative regulation of interleukin-17 production | 4.370615e-3 |
GO:0032229 | negative regulation of synaptic transmission, GABAergic | 4.370615e-3 |
GO:0046626 | regulation of insulin receptor signaling pathway | 4.406596e-3 |
GO:0002902 | regulation of B cell apoptosis | 4.425222e-3 |
GO:0061383 | trabecula morphogenesis | 4.427388e-3 |
GO:0006817 | phosphate ion transport | 4.449784e-3 |
GO:0032892 | positive regulation of organic acid transport | 4.449784e-3 |
GO:0071870 | cellular response to catecholamine stimulus | 4.482051e-3 |
GO:0043923 | positive regulation by host of viral transcription | 4.610597e-3 |
GO:0090324 | negative regulation of oxidative phosphorylation | 4.883491e-3 |
GO:0000379 | tRNA-type intron splice site recognition and cleavage | 4.883491e-3 |
GO:0015761 | mannose transport | 4.883491e-3 |
GO:0010756 | positive regulation of plasminogen activation | 4.883491e-3 |
GO:0010255 | glucose mediated signaling pathway | 4.883491e-3 |
GO:0097039 | protein linear polyubiquitination | 4.899328e-3 |
GO:0016098 | monoterpenoid metabolic process | 4.899328e-3 |
GO:0002536 | respiratory burst involved in inflammatory response | 4.916910e-3 |
GO:0048242 | epinephrine secretion | 4.924319e-3 |
GO:0051302 | regulation of cell division | 4.965399e-3 |
GO:0097084 | vascular smooth muscle cell development | 4.966985e-3 |
GO:0043248 | proteasome assembly | 4.966985e-3 |
GO:0032714 | negative regulation of interleukin-5 production | 4.991583e-3 |
GO:0051135 | positive regulation of NK T cell activation | 4.995461e-3 |
GO:0032722 | positive regulation of chemokine production | 4.999989e-3 |
GO:0006308 | DNA catabolic process | 5.070880e-3 |
GO:0060160 | negative regulation of dopamine receptor signaling pathway | 5.082698e-3 |
GO:0015746 | citrate transport | 5.082698e-3 |
GO:0007041 | lysosomal transport | 5.153891e-3 |
GO:0014895 | smooth muscle hypertrophy | 5.258815e-3 |
GO:0032065 | cortical protein anchoring | 5.258815e-3 |
GO:0003106 | negative regulation of glomerular filtration by angiotensin | 5.258815e-3 |
GO:0010976 | positive regulation of neuron projection development | 5.304800e-3 |
GO:0051148 | negative regulation of muscle cell differentiation | 5.372969e-3 |
GO:0032277 | negative regulation of gonadotropin secretion | 5.374312e-3 |
GO:0043372 | positive regulation of CD4-positive, alpha-beta T cell differentiation | 5.523775e-3 |
GO:0032274 | gonadotropin secretion | 5.523775e-3 |
GO:0001569 | patterning of blood vessels | 5.531074e-3 |
GO:0042129 | regulation of T cell proliferation | 5.569965e-3 |
GO:0021564 | vagus nerve development | 5.589446e-3 |
GO:0005979 | regulation of glycogen biosynthetic process | 5.639753e-3 |
GO:0070305 | response to cGMP | 5.754613e-3 |
GO:0016559 | peroxisome fission | 5.855816e-3 |
GO:2001020 | regulation of response to DNA damage stimulus | 5.865547e-3 |
GO:0032696 | negative regulation of interleukin-13 production | 6.031413e-3 |
GO:0060343 | trabecula formation | 6.101500e-3 |
GO:0050766 | positive regulation of phagocytosis | 6.158931e-3 |
GO:0035767 | endothelial cell chemotaxis | 6.171125e-3 |
GO:0060322 | head development | 6.214384e-3 |
GO:0071157 | negative regulation of cell cycle arrest | 6.290608e-3 |
GO:0048715 | negative regulation of oligodendrocyte differentiation | 6.291153e-3 |
GO:0006910 | phagocytosis, recognition | 6.315635e-3 |
GO:0033133 | positive regulation of glucokinase activity | 6.420225e-3 |
GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation | 6.536626e-3 |
GO:0060913 | cardiac cell fate determination | 6.634277e-3 |
GO:0031585 | regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity | 6.642367e-3 |
GO:0020027 | hemoglobin metabolic process | 6.686394e-3 |
GO:0045626 | negative regulation of T-helper 1 cell differentiation | 6.724502e-3 |
GO:0010845 | positive regulation of reciprocal meiotic recombination | 6.724502e-3 |
GO:0000238 | zygotene | 6.724502e-3 |
GO:0010661 | positive regulation of muscle cell apoptosis | 6.916641e-3 |
GO:0008210 | estrogen metabolic process | 6.940257e-3 |
GO:0042744 | hydrogen peroxide catabolic process | 7.156645e-3 |
GO:0032231 | regulation of actin filament bundle assembly | 7.214486e-3 |
GO:0035813 | regulation of renal sodium excretion | 7.470373e-3 |
GO:0046880 | regulation of follicle-stimulating hormone secretion | 7.566781e-3 |
GO:0048630 | skeletal muscle tissue growth | 7.566781e-3 |
GO:0045683 | negative regulation of epidermis development | 7.726193e-3 |
GO:0070537 | histone H2A K63-linked deubiquitination | 7.744662e-3 |
GO:0042396 | phosphagen biosynthetic process | 7.744662e-3 |
GO:0033159 | negative regulation of protein import into nucleus, translocation | 7.744662e-3 |
GO:0045730 | respiratory burst | 7.795072e-3 |
GO:0032868 | response to insulin stimulus | 7.919303e-3 |
GO:0009411 | response to UV | 7.926137e-3 |
GO:0030263 | apoptotic chromosome condensation | 7.951170e-3 |
GO:0051586 | positive regulation of dopamine uptake | 7.951170e-3 |
GO:0010518 | positive regulation of phospholipase activity | 8.022180e-3 |
GO:0021993 | initiation of neural tube closure | 8.107402e-3 |
GO:0010511 | regulation of phosphatidylinositol biosynthetic process | 8.107402e-3 |
GO:0030223 | neutrophil differentiation | 8.142707e-3 |
GO:0033602 | negative regulation of dopamine secretion | 8.364079e-3 |
GO:2000191 | regulation of fatty acid transport | 8.451813e-3 |
GO:0051131 | chaperone-mediated protein complex assembly | 8.530299e-3 |
GO:0090002 | establishment of protein localization in plasma membrane | 8.530299e-3 |
GO:0010569 | regulation of double-strand break repair via homologous recombination | 8.547029e-3 |
GO:0090280 | positive regulation of calcium ion import | 8.620116e-3 |
GO:0006102 | isocitrate metabolic process | 8.620116e-3 |
GO:2000108 | positive regulation of leukocyte apoptosis | 8.804002e-3 |
GO:0033566 | gamma-tubulin complex localization | 8.836624e-3 |
GO:0031627 | telomeric loop formation | 8.836624e-3 |
GO:0061302 | smooth muscle cell-matrix adhesion | 8.836624e-3 |
GO:0021919 | BMP signaling pathway involved in spinal cord dorsal/ventral patterning | 8.836624e-3 |
GO:0016068 | type I hypersensitivity | 8.836624e-3 |
GO:0018230 | peptidyl-L-cysteine S-palmitoylation | 8.836624e-3 |
GO:0006782 | protoporphyrinogen IX biosynthetic process | 8.988159e-3 |
GO:0006273 | lagging strand elongation | 8.988159e-3 |
GO:0043951 | negative regulation of cAMP-mediated signaling | 9.005059e-3 |
GO:0015793 | glycerol transport | 9.005059e-3 |
GO:0010991 | negative regulation of SMAD protein complex assembly | 9.005059e-3 |
GO:0019058 | viral infectious cycle | 9.083360e-3 |
GO:0002385 | mucosal immune response | 9.171290e-3 |
GO:0010667 | negative regulation of cardiac muscle cell apoptosis | 9.200388e-3 |
GO:0019835 | cytolysis | 9.512339e-3 |
GO:0033599 | regulation of mammary gland epithelial cell proliferation | 9.679752e-3 |
GO:0035441 | cell migration involved in vasculogenesis | 9.824546e-3 |
GO:0002251 | organ or tissue specific immune response | 1.026786e-2 |
GO:0055070 | copper ion homeostasis | 1.026786e-2 |
GO:0050731 | positive regulation of peptidyl-tyrosine phosphorylation | 1.034733e-2 |
GO:0046890 | regulation of lipid biosynthetic process | 1.038783e-2 |
GO:0071321 | cellular response to cGMP | 1.043854e-2 |
GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline | 1.043854e-2 |
GO:0001765 | membrane raft assembly | 1.043854e-2 |
GO:0033081 | regulation of T cell differentiation in thymus | 1.064573e-2 |
GO:0010717 | regulation of epithelial to mesenchymal transition | 1.072704e-2 |
GO:0048241 | epinephrine transport | 1.076077e-2 |
GO:0051590 | positive regulation of neurotransmitter transport | 1.076941e-2 |
GO:0043552 | positive regulation of phosphatidylinositol 3-kinase activity | 1.082646e-2 |
GO:0046092 | deoxycytidine metabolic process | 1.082733e-2 |
GO:0003094 | glomerular filtration | 1.082733e-2 |
GO:0002575 | basophil chemotaxis | 1.082733e-2 |
GO:0002432 | granuloma formation | 1.082733e-2 |
GO:0034619 | cellular chaperone-mediated protein complex assembly | 1.087702e-2 |
GO:0051875 | pigment granule localization | 1.102407e-2 |
GO:2000484 | positive regulation of interleukin-8 secretion | 1.116646e-2 |
GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation | 1.116798e-2 |
GO:0060375 | regulation of mast cell differentiation | 1.133625e-2 |
GO:0071247 | cellular response to chromate | 1.146583e-2 |
GO:0071881 | inhibition of adenylate cyclase activity by adrenergic receptor signaling pathway | 1.146583e-2 |
GO:0071882 | activation of phospholipase C activity by adrenergic receptor signaling pathway | 1.146583e-2 |
GO:0032900 | negative regulation of neurotrophin production | 1.146583e-2 |
GO:0000059 | protein import into nucleus, docking | 1.146583e-2 |
GO:0010760 | negative regulation of macrophage chemotaxis | 1.146583e-2 |
GO:0018214 | protein carboxylation | 1.146583e-2 |
GO:0032244 | positive regulation of nucleoside transport | 1.146583e-2 |
GO:0019067 | viral assembly, maturation, egress, and release | 1.157976e-2 |
GO:0008333 | endosome to lysosome transport | 1.196573e-2 |
GO:0043631 | RNA polyadenylation | 1.217080e-2 |
GO:0050760 | negative regulation of thymidylate synthase biosynthetic process | 1.218280e-2 |
GO:0043137 | DNA replication, removal of RNA primer | 1.218280e-2 |
GO:0007174 | epidermal growth factor catabolic process | 1.218280e-2 |
GO:0015732 | prostaglandin transport | 1.218280e-2 |
GO:0010740 | positive regulation of intracellular protein kinase cascade | 1.229793e-2 |
GO:0006099 | tricarboxylic acid cycle | 1.237961e-2 |
GO:0032846 | positive regulation of homeostatic process | 1.240033e-2 |
GO:0060159 | regulation of dopamine receptor signaling pathway | 1.240406e-2 |
GO:0051006 | positive regulation of lipoprotein lipase activity | 1.241047e-2 |
GO:0045647 | negative regulation of erythrocyte differentiation | 1.241047e-2 |
GO:0006626 | protein targeting to mitochondrion | 1.252549e-2 |
GO:0051954 | positive regulation of amine transport | 1.258515e-2 |
GO:0048013 | ephrin receptor signaling pathway | 1.271267e-2 |
GO:0032606 | type I interferon production | 1.281051e-2 |
GO:0033137 | negative regulation of peptidyl-serine phosphorylation | 1.306819e-2 |
GO:0043467 | regulation of generation of precursor metabolites and energy | 1.309033e-2 |
GO:0050863 | regulation of T cell activation | 1.309920e-2 |
GO:0022616 | DNA strand elongation | 1.332672e-2 |
GO:0032436 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process | 1.342709e-2 |
GO:0009062 | fatty acid catabolic process | 1.358055e-2 |
GO:0050432 | catecholamine secretion | 1.360374e-2 |
GO:0043921 | modulation by host of viral transcription | 1.374241e-2 |
GO:0009914 | hormone transport | 1.396391e-2 |
GO:0032228 | regulation of synaptic transmission, GABAergic | 1.396776e-2 |
GO:0034103 | regulation of tissue remodeling | 1.400718e-2 |
GO:0051436 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 1.409307e-2 |
GO:0050917 | sensory perception of umami taste | 1.409307e-2 |
GO:0032784 | regulation of transcription elongation, DNA-dependent | 1.422005e-2 |
GO:0048545 | response to steroid hormone stimulus | 1.422726e-2 |
GO:0045835 | negative regulation of meiosis | 1.428245e-2 |
GO:0045358 | negative regulation of interferon-beta biosynthetic process | 1.449916e-2 |
GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway | 1.449916e-2 |
GO:0021586 | pons maturation | 1.449916e-2 |
GO:0002478 | antigen processing and presentation of exogenous peptide antigen | 1.452439e-2 |
GO:0090150 | establishment of protein localization in membrane | 1.457482e-2 |
GO:0042321 | negative regulation of circadian sleep/wake cycle, sleep | 1.460907e-2 |
GO:0046544 | development of secondary male sexual characteristics | 1.460907e-2 |
GO:0044342 | type B pancreatic cell proliferation | 1.479412e-2 |
GO:0042996 | regulation of Golgi to plasma membrane protein transport | 1.479412e-2 |
GO:0008298 | intracellular mRNA localization | 1.479412e-2 |
GO:0030321 | transepithelial chloride transport | 1.481595e-2 |
GO:0006991 | response to sterol depletion | 1.481595e-2 |
GO:0051492 | regulation of stress fiber assembly | 1.488638e-2 |
GO:0014707 | branchiomeric skeletal muscle development | 1.492103e-2 |
GO:0046125 | pyrimidine deoxyribonucleoside metabolic process | 1.492103e-2 |
GO:0032849 | positive regulation of cellular pH reduction | 1.499115e-2 |
GO:0045332 | phospholipid translocation | 1.506801e-2 |
GO:0010700 | negative regulation of norepinephrine secretion | 1.506801e-2 |
GO:0040009 | regulation of growth rate | 1.506801e-2 |
GO:0050909 | sensory perception of taste | 1.507102e-2 |
GO:0051096 | positive regulation of helicase activity | 1.508248e-2 |
GO:0001835 | blastocyst hatching | 1.508248e-2 |
GO:0045116 | protein neddylation | 1.508248e-2 |
GO:0043088 | regulation of Cdc42 GTPase activity | 1.520094e-2 |
GO:0019218 | regulation of steroid metabolic process | 1.523976e-2 |
GO:0035025 | positive regulation of Rho protein signal transduction | 1.575669e-2 |
GO:0050768 | negative regulation of neurogenesis | 1.597822e-2 |
GO:0006635 | fatty acid beta-oxidation | 1.602289e-2 |
GO:0014819 | regulation of skeletal muscle contraction | 1.603533e-2 |
GO:0032855 | positive regulation of Rac GTPase activity | 1.607901e-2 |
GO:0034616 | response to laminar fluid shear stress | 1.616052e-2 |
GO:0006670 | sphingosine metabolic process | 1.617063e-2 |
GO:0046113 | nucleobase catabolic process | 1.621820e-2 |